MCK
McKesson Corp
$863.61
22.04 (2.51%) Today
6.91 (0.81%) After-hours
— up— down
Market Cap
$102.45B+29.2%
Revenue (TTM)
$403.67B+8.8%
Net Income (TTM)
$4.37B+49.1%
EPS (TTM)
37.35+49.1%
Shares Out
117.08M
117.08MP/E Ratio
21.89
21.89Forward P/E
18.72
18.72Dividend
$3.11 (0.43%)
$3.11 (0.43%)Ex-Dividend Date
Jun 1, 2026
Jun 1, 2026Open
$873.09
$873.09Previous Close
$878.73
$878.73Day Range
$856.69 – $875.46
$856.69 – $875.4652-Week Range
$661.69 – $999.00
$661.69 – $999.00Beta
0.30
0.30Volume
784.85K
784.85KAvg Volume
1.09M
1.09MAnalyst Rating
Buy
BuyExchange
NEW YORK STOCK EXCHANGE, INC.
NEW YORK STOCK EXCHANGE, INC.About MCK
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
Related
News
N/AN/AN/A
N/A
Wells Fargo Maintains Equal-Weight on McKesson, Raises Price Target to $933
Benzinga · 2d ago
McKesson Q1 Earnings Call Highlights
Yahoo · 5d ago
How Higher Sales, Lower EPS And New Guidance At McKesson (MCK) Has Changed Its Investment Story
Yahoo · 5d ago

McKesson: Solid Q1 Earnings And Management Execution (Rating Upgrade)
SeekingAlpha · 5d ago
McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why
Yahoo · 6d ago